BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G901. A total of 7 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $856,000 | -50.3% | 9,600 | -48.1% | 0.06% | -65.6% |
Q3 2017 | $1,722,000 | -31.8% | 18,500 | -33.5% | 0.16% | +68.4% |
Q2 2017 | $2,525,000 | +2.7% | 27,800 | -0.7% | 0.10% | +427.8% |
Q1 2017 | $2,458,000 | -34.9% | 28,000 | -38.6% | 0.02% | +5.9% |
Q4 2016 | $3,778,000 | -2.6% | 45,600 | +8.8% | 0.02% | -10.5% |
Q3 2016 | $3,877,000 | -21.6% | 41,900 | -34.1% | 0.02% | -17.4% |
Q2 2016 | $4,948,000 | +55.8% | 63,600 | +65.2% | 0.02% | +53.3% |
Q1 2016 | $3,175,000 | -30.0% | 38,500 | -11.1% | 0.02% | -31.8% |
Q4 2015 | $4,536,000 | +74.4% | 43,300 | +75.3% | 0.02% | +100.0% |
Q3 2015 | $2,601,000 | +98.1% | 24,700 | +157.3% | 0.01% | +83.3% |
Q2 2015 | $1,313,000 | -80.9% | 9,600 | -82.6% | 0.01% | -80.6% |
Q1 2015 | $6,879,000 | +410.7% | 55,200 | +270.5% | 0.03% | +520.0% |
Q4 2014 | $1,347,000 | -58.8% | 14,900 | -67.1% | 0.01% | -64.3% |
Q3 2014 | $3,269,000 | -17.1% | 45,300 | -28.5% | 0.01% | -22.2% |
Q2 2014 | $3,944,000 | -1.3% | 63,400 | +8.2% | 0.02% | +5.9% |
Q1 2014 | $3,997,000 | +317.7% | 58,600 | +330.9% | 0.02% | +466.7% |
Q4 2013 | $957,000 | -27.9% | 13,600 | -26.1% | 0.00% | -40.0% |
Q3 2013 | $1,328,000 | -57.7% | 18,400 | -67.3% | 0.01% | -58.3% |
Q2 2013 | $3,138,000 | – | 56,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hudson Bay Capital Management LP | 145,000 | $11,960,000 | 0.56% |
GROUP ONE TRADING, L.P. | 65,100 | $5,369,000 | 0.08% |
Timber Hill LLC | 38,500 | $3,175,000 | 0.02% |
SIMPLEX TRADING, LLC | 438 | $141,000 | 0.01% |
Citadel Advisors | 37,000 | $3,052,000 | 0.00% |
SG Americas Securities, LLC | 14,000 | $49,000 | 0.00% |